Euglycemic diabetic ketoacidosis (DKA) is a serious and potentially life-threatening complication of diabetes mellitus. It is characterized by the presence of ketone bodies in the blood along with hyperglycemia and acidosis. Although the exact cause of euglycemic DKA is not known, it is believed to be related to an imbalance in the body's ability to produce and use insulin. In this article, we will discuss how to break the cycle of euglycemic DKA and achieve lasting control.
Euglycemic DKA is a type of DKA in which the blood glucose levels are elevated but not at a level that would normally be considered diabetic. It is often referred to as “silent DKA” because it is not usually associated with the traditional symptoms of DKA such as polyuria and polydipsia. It is more common in type 2 diabetes but can occur in type 1 as well. The most common cause of euglycemic DKA is an imbalance in the body's ability to produce and use insulin. This can be due to a variety of factors such as changes in medication, insulin resistance, or a lack of adherence to a diabetes management plan. It can also be caused by a sudden increase in physical activity or stress.
Euglycemic DKA can be difficult to diagnose because the symptoms may not be as pronounced as with traditional DKA. It is important to be aware of the signs and symptoms of euglycemic DKA so that it can be identified and treated as soon as possible. The most common symptoms of euglycemic DKA include: • Elevated blood glucose levels • Ketone bodies in the urine • Abnormal blood acidity • Nausea and vomiting • Abdominal pain • Fatigue If any of these symptoms are present, it is important to seek medical attention as soon as possible.
The goal of treating euglycemic DKA is to reduce the risk of further complications and restore normal blood glucose levels. Treatment typically involves a combination of medications, lifestyle changes, and close monitoring of blood glucose levels. Medications: Medications such as insulin, sulfonylureas, and thiazolidinediones can be used to help control blood glucose levels. Lifestyle Changes: Making healthy lifestyle changes such as eating a balanced diet, exercising regularly, and getting enough sleep can help to reduce the risk of euglycemic DKA. Monitoring: Regular monitoring of blood glucose levels is essential for managing euglycemic DKA.
The best way to prevent euglycemic DKA is to maintain good control of your diabetes. This means following your doctor's instructions for taking medications, eating a healthy diet, exercising regularly, and monitoring your blood glucose levels. It is also important to be aware of the signs and symptoms of euglycemic DKA and to seek medical attention if they are present.
Euglycemic DKA is a serious and potentially life-threatening complication of diabetes mellitus. It is important to be aware of the signs and symptoms of euglycemic DKA and to seek medical attention if they are present. Treatment typically involves a combination of medications, lifestyle changes, and close monitoring of blood glucose levels. The best way to prevent euglycemic DKA is to maintain good control of your diabetes.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation